Strategic Partnerships Akesis has a history of strategic collaborations with MagnetTx, University Hospitals Seidman Cancer Center, Prowess, and Zahrawi Group. Leverage these relationships to identify co-selling opportunities, joint demonstrations, and regional deployment partnerships that could accelerate adoption of Gemini360RT and Galaxy RTi.

Clinical Adoption Momentum Recent activity includes the first US patient treatment with Gemini360RT in December 2025 and ongoing FDA clearance for key systems. Target hospitals and oncology centers expanding radiation therapy programs, emphasizing online and offline adaptive therapy capabilities to address growing demand for adaptive, precise treatments.

Global Market Access Akesis positions its systems as globally relevant with US assembly and regulatory rigor. Opportunities exist in international markets seeking advanced rotational therapy and real-time imaging, especially in regions where access to cutting-edge radiation oncology is expanding and where partnerships can facilitate regulatory navigation.

Growth Through PEERS With a lean team (11-50 employees) and revenue in the low-to-mid single digits, Akesis could benefit from channel and affiliate models, including regional distributors or systems integrators, to scale sales coverage, installation, and after-sales service across multiple hospitals.

Value Proposition for Care Networks Customer targets include major cancer centers and academic hospitals through collaborations, patient access initiatives, and turnkey deployment of adaptive therapy platforms. Emphasize reduced treatment times, improved planning flexibility, and integrated imaging to align with value-based care and expand payer-facing narratives.